Recent Updates
Recently added Catalysts
RARE

Ultragenyx Announces Crysvita (burosumab) and UX143 (setrusumab) Data Presentations at Upcoming American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting

Monday, September 27, 2021 1 min read
Key Takeaway: Ultragenyx Announces Crysvita (burosumab) and UX143 (setrusumab) Data Presentations at Upcoming American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting

Full Press Release Details

Ultragenyx Announces Crysvita (burosumab) and UX143 (setrusumab) Data Presentations at Upcoming American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting.
Tags: RARE Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Sep 27, 2021